OTC Markets OTCPK - Delayed Quote USD

Viva Biotech Holdings (VBIZF)

0.0950

-0.0732

(-43.52%)

As of January 24 at 3:00:00 PM EST. Market Open.

Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion

Recently, Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston, USA. As a global leader in drug research, development and manufacturing services, this milestone marks a significant step forward in the company's global expansion strategy. Viva Biotech aims to further enhance and deepen international collaboration networks, providing comprehensive one-stop CRO-CMC/CDMO services—from drug discovery and preclinical development to commercial ma

PR Newswire last month

VBIZF
-43.52%
Discover December 2024's Top Penny Stocks

Global markets have recently experienced a series of gains, with major indices such as the Dow Jones Industrial Average and S&P 500 Index reaching record intraday highs, despite geopolitical tensions and domestic policy shifts influencing investor sentiment. Amid these developments, the concept of penny stocks—often associated with smaller or newer companies—continues to capture interest due to their affordability and potential for growth. While the term may seem outdated, these stocks can...

Simply Wall St. last month

VBIZF
-43.52%
0909.HK
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms

On August 29, 2024, Viva Biotech Holdings Group ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that the Group achieved a revenue RMB981.8 million; and the Group's gross profit of RMB339.1 million. The Group's net profit amounted to RMB144.2 million, a significant improvement from the net profit of RMB13.7 million for the corresponding period of last year, mainly benefiting from the elimination of relevant financial adjustments due to the full repayment of convertib

PR Newswire 4 months ago

VBIZF
-43.52%
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future

On March 28, 2024, Viva Biotech Holdings Group ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that the Group's revenue during the Reporting Period achieved RMB2,155.6 million; and our gross profit amounted to RMB738.5 million. In 2023, the Group's net loss amounted to RMB99.8 million, a significant improvement from a loss of RMB504.2 million for the corresponding period of last year. Adjusted non-IFRS net loss improved from RMB133.9 million for the corresponding pe

PR Newswire 9 months ago

VBIZF
-43.52%

Performance Overview

Return	VBIZF	HANG SENG INDEX
YTD	+33.99%	+0.78%
1-Year	+2.70%	+26.61%
3-Year	-80.47%	-16.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Viva Biotech Holdings (VBIZF)

Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion

Discover December 2024's Top Penny Stocks

Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms

Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future

Performance Overview